Pendopharm logo
  • About Us
  • Areas of Focus
  • Products
  • Partnering
  • News
  • Careers
Contact Us
  • Terms and Conditions of Use
  • Privacy Policy
  • About Us
  • Areas of Focus
  • Products
  • Partnering
  • News
  • Careers
  • fr
Contact Us
PENDOPHARM AND YOU:

Growing Together

Visit our parent company Pharmascience careers website to explore available positions.
VISIT THE CAREERS WEBSITE

News

Welcome to our newsroom – get the latest news and updates from Pendopharm.

Business News
Posted on August 27, 2021

Health Canada Approves MYINFLATM (Colchicine 0.5 mg Extended-Release Tablets), a New Repurposed Treatment for Cardiovascular Disease

Read More
Posted on November 16, 2019

Pharmascience inc. contributes to the Montreal Heart Institute’s Colchicine Cardiovascular Outcome Trial (COLCOT)

Read More
Posted on November 12, 2018

PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award

Read More
Posted on February 20, 2018

PENDOPHARM a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals

Read More
Posted on September 22, 2017

PENDOPHARM, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada

Read More
  • 1
  • 2
  • →
Publications
  • All
  • Award / Recognition
  • Business News
  • Employer awards
  • Partnership
  • Press releases
  • Product Launch
  • Product Update

Media Relations

Please send us an email and provide us with your contact information as well as the name of your media/publication/source. A member of our team will contact you back quickly.

Contact Us

If you are not a member of the media, please see additional contact information on our Contact Us page

Contact Us
Pendopharm logo
Contact Us

© 2025 Pendopharm. All rights reserved

  • Terms and Conditions of Use
  • Privacy Policy